Evidence map›Paper›PMID 21520177›Full record

ArticleHepatology (Baltimore, Md.)2011

Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice.

Arun Thenappan, Vivek Shukla, Feras J Abdul Khalek, Ying Li, Kirti Shetty, Pu Liu, Lu Li, Randy L Johnson, Lynt Johnson, Lopa Mishra

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The complexity of TGFβ/activin signaling in regeneration.Journal of cell communication and signaling · 2021
    Review
  5. Liver regeneration: biological and pathological mechanisms and implications.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Spectrin and its interacting partners in nuclear structure and function.Experimental biology and medicine (Maywood, N.J.) · 2018
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Arun ThenappanDepartment of Surgery, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Vivek Shukla
Feras J Abdul Khalek
Ying Li
Kirti Shetty
Pu Liu
Lu Li
Randy L Johnson
Lynt Johnson
Lopa Mishra
The University of Texas MD Anderson Cancer Center · USGeorgetown University · USCancer Genetics (United States) · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Targeting CDK4 in TGS-B Inactivated Gastrointestinal CancersP01CA130821 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MISHRA, LOPA · 2008 to 2013
$6.9M
METASTATIC POTENTIAL OF HUMAN COLORECTAL CARCINOMAR01CA042857 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MISHRA, LOPA · 1986 to 2010
$3.2M
TLR4 and TGF-beta interactions in HCC induced by HCV and alcoholRC2AA019392 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2009 to 2010
$1.9M
Gastrointestinal Cell Proliferation and Cell CycleR01CA106614 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MISHRA, LOPA · 2005 to 2009
$1.5M
NCI NIH HHS P01 CA130821NCI NIH HHS P01CA130821NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA042857NCI NIH HHS R01CA042857NCI NIH HHS R01 CA106614NCI NIH HHS R01CA106614NIAAA NIH HHS RC2 AA019392NIAAA NIH HHS RC2-AA019392
6 · The paper itself

Abstract

unlabelledLiver regeneration, following partial hepatectomy (PHx), occurs through precisely controlled and synchronized cell proliferation, in which quiescent hepatocytes undergo one to two rounds of replication, with restoration of liver mass and function. We previously demonstrated that loss of the Smad3/4 adaptor protein β-2 spectrin (β2SP) is associated with faster entry into S phase, and hepatocellular cancer formation. These observations led us to further pursue the role of β2SP in cell cycle progression in vivo. Liver regeneration studies with PHx in β2SP(+/-) mice reveal a surprising and significant decrease in liver/body weight ratio at 48 hours after PHx in β2SP(+/-) mice in comparison to wildtype mice. At 48 hours after PHx we also observe decreased levels of cyclin E (2.4-fold, P < 0.05), Cdk1 (7.2-fold, P < 0.05), cyclin A, pRb (Ser249/Thr252), proliferative cell nuclear antigen (PCNA), cyclin D1 with elevated levels of pCdk1 (Thr14) (3.6-fold, P < 0.05). Strikingly, at 24 hours elevated levels of p53 (4-fold, P < 0.05), phospho-p53 (ser15 and ser20), and p21 (200-fold, P < 0.05) persisting to 48 hours after PHx further correlated with raised expression of the DNA damage markers pChk2 (Thr68) and γH2AX (S139). However, compromised cell cycle progression with loss of β2SP is not rescued by inhibiting p53 function, and that G(2) /M phase arrest observed is independent and upstream of p53.

conclusionβ2SP deficiency results in dysfunctional hepatocyte cell cycle progression and delayed liver regeneration at 48 hours after PHx, which is p53-independent. β2SP loss may increase susceptibility to DNA damage, impair cell cycle progression, and ultimately lead to hepatocellular cancer.

Indexed as

AnimalsCarrier ProteinsCell CycleCyclin-Dependent Kinase Inhibitor p21Liver RegenerationMiceMicrofilament ProteinsReceptors, Transforming Growth Factor betaSpectrinTime FactorsTumor Suppressor Protein p53Carrier ProteinsCyclin-Dependent Kinase Inhibitor p21Microfilament ProteinsReceptors, Transforming Growth Factor betaSpectrinTumor Suppressor Protein p53

Identifiers

PMID21520177
PMCPMC3162320
OpenAlexW2051664064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.